CCR5 and neoplasm: We confirmed that MAMPCs and MAMs in the metastatic lung expressed significantly higher levels of CD14, CD36, CD64 (Fcgr1), CD206 (Mrc1) and CCR5 proteins compared with circulating C-MOs in the tumor-bearing mice (Figure 3F).